ANI Pharmaceuticals, Inc. (ANIP) vs Prestige Consumer Healthcare Inc. (PBH)
- ANI Pharmaceuticals, Inc. ANIP 72.08 −0.28%
- Prestige Consumer Healthcare Inc. PBH 49.92 +1.46%
ANI Pharmaceuticals, Inc. and Prestige Consumer Healthcare Inc. are both Drug Manufacturers Specialty & Generic companies. Prestige Consumer Healthcare Inc. is the larger, with a market value of $2.3B against $1.7B — 1.4× the size. Prestige Consumer Healthcare Inc. trades at the lower P/E: 13.9× against 14.9×. ANI Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 30.9% against −1.36%. Prestige Consumer Healthcare Inc. has the higher net margin (15.6% vs 11.0%) and the lower return on invested capital (4.70% vs 11.3%). Across the 22 metrics below, ANI Pharmaceuticals, Inc. leads on 14 and Prestige Consumer Healthcare Inc. on 8.
Valuation
Profitability
| Metric | ANIP | PBH | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 60.40% | 53.53% | 53.94% |
| Operating margin | 15.37% | 26.26% | 0.00% |
| Net margin | 11.04% | 15.57% | 0.00% |
| Free cash flow margin | 17.12% | 21.30% | 0.00% |
| Return on equity | 20.88% | 9.12% | (0.40%) |
| Return on assets | 7.61% | 4.30% | (3.32%) |
| Return on invested capital | 11.30% | 4.70% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack